BBC reporter Charlie Buckland explains what they are and how they work.

Wes Streeting’s new plan to give obese patients weight loss injections so they can return to work was torn apart by a doctor this morning. This new medication – part of a £279m investment from the world’s largest pharmaceutical company Lilly – is to be tested in the first real-world trial of the drugs’ impact on “worklessness”.

The Prime Minister said the anti-obesity medication could help people "get back into work" and reduce pressure on the NHS, while Labour leader Sir Keir Starmer said it could also help ease pressure on

The upcoming approval for the NHS to use another injection, called Mounjaro, dubbed by some as the King Kong of weight loss jabs for how well it appears works in trials, is expected to place even more pressure on the system, the report warns.

Weight-loss jabs are “not the holy grail”, the NHS medical director has said. Prof Sir Stephen Powis said the drugs would be a “revolutionary” part of the approach that Britain takes to obesity. But he said the country “cannot simply treat our way out of the obesity crisis”,

Proposals to give weight loss jabs to unemployed people living with obesity could be "very important" for our economy and health, the prime minister has told the BBC. Sir Keir Starmer said while he acknowledged that more money was needed for the NHS the government also needed to "think differently" to ease pressure on the health system.

An NHS doctor has criticised Labour's plan to trial weight loss injections for unemployed Britons, raising concerns over drug shortages and long-term effectiveness. The initiative, proposed by Shadow Health Secretary Wes Streeting,